Skip to content

Using SystemCHANGE™ to Enhance Medication Adherence in Older Adult Stroke Survivors

Randomized Controlled Pilot Study of a SystemCHANGE™ Medication Adherence Intervention in Older Adult Stroke Survivors

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03211130
Enrollment
30
Registered
2017-07-07
Start date
2017-11-28
Completion date
2018-05-24
Last updated
2019-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Ischemic

Keywords

medication adherence, self-management, antithrombotic

Brief summary

This study evaluated the feasibility and acceptability of using a SystemCHANGE intervention in older adult stroke survivors to improve medication adherence. Half the participants will receive the SystemCHANGE intervention, while the other half will receive the attention-control education intervention.

Interventions

BEHAVIORALSystemCHANGE™

During the intervention phase, the PI will visit both groups of participants at home at baseline and telephone them three times (day 3 ±2 days and months 1 and 2). Refer to tables 1 and 2 for intervention details. Treatment participants will implement SystemCHANGE™ activities related to medication taking with the assistance of the PI while attention-control participants will receive patient education materials on stroke. Perceived health data will be collected during the intervention phase. A 1-month maintenance phase follows the intervention phase. Electronic medication monitoring continues, but no intervention is delivered to either group.

An experienced stroke nurse will deliver the attention control intervention. Table 3.2 shows the 2-month attention-control intervention. The stroke materials were developed by the Saint Luke's Marion Bloch Neuroscience Institute and are given to every stroke patient prior to dismissal. The PI will call participants at day 3 ±2 days, and months 1 and 2 to review chapter(s) from the book and answer questions about it. Interval, frequency, and setting are all exactly the same for the intervention and control groups. If the control participant raises questions about medications or medication-taking, PI will refer them to their Neurologist.

Sponsors

Saint Luke's Health System
CollaboratorOTHER
University of Missouri, Kansas City
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* age ≥50 years old * receives post-stroke care with Saint Luke's Neurological Consultants * prescribed at least 1, once a day, antithrombotic medication * able to provide informed consent * able to open an electronic cap * able to self-administer medications * has or has access to a telephone * has no cognitive impairment as determined by a score of 4 or greater on The Six- item Screener (SIS).

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Acceptability and feasibilityone point in time at the end of the maintenance phase which is 3 months after randomization into groupsOpen ended questionnaire

Secondary

MeasureTime frameDescription
Social SupportOne day at beginning of Intervention phase. Once 1 day at beginning of Maintenance phase.The Social Support Appraisals Index (SS-A) is a 23-item self-administered, a self-report scale measuring the degree to which a person feels cared for, respected, and involved with family and friends. The scale had good reliability and validity (Cronbach α coefficients .90, .81, and .84) (Vaux et al., 1986).
Perceived HealthOne day at beginning of Intervention phase. Once 1 day at beginning of Maintenance phase.Perceived health status will be measured by one question, How is your health in general? Participant select excellent, very good, good, fair, poor, or very poor. Perceived health status reflects people's overall perception of their health, including both physical and psychological dimensions.
Personal Systems BehaviorsOne day at beginning of Intervention phase. Once 1 day at beginning of Maintenance phase.The Systems Thinking Survey (adapted for patients), a 20-item, 5-point Likert response scale measuring perceptions of personal system behaviors.
Medication Adherenceafter randomization through end of maintenance phase for a total of 3 monthsMA data will be retrieved from the MEMS®cap which is a medication cap containing a battery and microelectronics that records the date and the time of each cap removal to create a medication event (MEMS® Cap versatile adherence monitoring cap, n.d.).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026